These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1577007)

  • 1. H8 chemical shifts in oligonucleotide cross-linked at a GpG sequence by cis-Pt(NH3)2(2+): a clue to the adduct structure.
    Kozelka J; Fouchet MH; Chottard JC
    Eur J Biochem; 1992 May; 205(3):895-906. PubMed ID: 1577007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixing the conformations of diamineplatinum(II)-GpG chelates: NMR and CD signatures of individual rotamers.
    Over D; Bertho G; Elizondo-Riojas MA; Kozelka J
    J Biol Inorg Chem; 2006 Mar; 11(2):139-52. PubMed ID: 16429316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10703-13. PubMed ID: 12940756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1H and 31P NMR study of cis-Pt(NH3)2[d(CpGpG)-N7(2),N7(3)]. The influence of a 5'-terminal cytosine, on the structure of the cis-Pt(NH3)2[d(GpG)-N7,N7] intrastrand cross-link.
    den Hartog JH; Altona C; van der Marel GA; Reedijk J
    Eur J Biochem; 1985 Mar; 147(2):371-9. PubMed ID: 2982616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG).
    Chifotides HT; Dunbar KR
    Chemistry; 2006 Aug; 12(25):6458-68. PubMed ID: 16900545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts.
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    J Am Chem Soc; 2001 Sep; 123(38):9345-55. PubMed ID: 11562217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecificity and enantioselectivity in the binding of the platinum(II) complex [PtCl2(tmdz)] (tmdz = 5,5,7-trimethyl-1,4-diazacycloheptane) to dinucleotides and oligonucleotides.
    Munk VP; Diakos CI; Messerle BA; Fenton RR; Hambley TW
    Chemistry; 2002 Dec; 8(23):5486-93. PubMed ID: 12561321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.
    Mellish KJ; Qu Y; Scarsdale N; Farrell N
    Nucleic Acids Res; 1997 Mar; 25(6):1265-71. PubMed ID: 9092638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
    Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
    Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes.
    Ober M; Lippard SJ
    J Am Chem Soc; 2008 Mar; 130(9):2851-61. PubMed ID: 18269283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprinting structural information from a GpG ligand into the configuration of a chiral diamine ligand through second-sphere communication in platinum(II) complexes.
    Williams KM; Scarcia T; Natile G; Marzilli LG
    Inorg Chem; 2001 Jan; 40(3):445-54. PubMed ID: 11209600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of the adduct cis-[Pt(NH3)2 d(GpG)]+ in aqueous solution. A high field (500-300 MHz) nuclear magnetic resonance investigation.
    den Hartog JH; Altona C; Chottard JC; Girault JP; Lallemand JY; de Leeuw FA; Marcelis AT; Reedijk J
    Nucleic Acids Res; 1982 Aug; 10(15):4715-30. PubMed ID: 6890203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-Platinum induced distortions in DNA. Conformational analysis of d(GpCpG) and cis-pt(NH3)2[d(GpCpG)], studied by 500-MHz NMR.
    den Hartog JH; Altona C; van Boom JH; Marcelis AT; van der Marel GA; Rinkel LJ; Wille-Hazeleger G; Reedijk J
    Eur J Biochem; 1983 Aug; 134(3):485-95. PubMed ID: 6684039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cis-[Pt(NH3)2(H2O)2](NO3)2 with ribose deoxyribose diguanosine phosphates.
    Girault JP; Chottard G; Lallemand JY; Chottard JC
    Biochemistry; 1982 Mar; 21(6):1352-6. PubMed ID: 6280759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D; Gaucheron F; Sip M; Leng M
    Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dT20 and [d(AT)10]2 on cisplatin hydrolysis studied by two-dimensional [1H,15N] HMQC NMR spectroscopy.
    Vinje J; Sletten E; Kozelka J
    Chemistry; 2005 Jun; 11(13):3863-71. PubMed ID: 15827978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication".
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    Inorg Chem; 2001 Jan; 40(3):455-62. PubMed ID: 11209601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM
    Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.